These findings offer promising therapeutic targets, including the modulation of JAK‐STAT signaling and the restoration of brain connectivity, which hold the potential for developing more effective interventions and treatment approaches tailored specifically for patients with depression following frontal lobe hemorrhage. The gene discussed is SOAT1; the disease is depressive symptom measurement.